Representative Matters

In his practice, Mr. Dougall has:

  • Represented Dr. Glenn J. Donovan, DPM, a defendant in the civil False Claims Act litigation entitled United States of America and New York State ex rel. Irina Gelman, DPM v. Glenn J. Donovan, DPM, New York City Health and Hospitals Corporation, and Physician Affiliate Group of New York, P.C., No. 1:12-cv-05142-RJD-SJB (EDNY). Dr. Donovan has categorically denied any claimed wrongdoing or liability in the litigation with his Answer filed with the Court. The case is currently in discovery.
  • Represented an investment advisor, its managed venture capital funds and its board representative in fiduciary duty litigation concerning a publicly traded tech company.
  • Represented a multinational and publicly traded pharmaceutical and medical device manufacturer in various health care fraud and antitrust investigations by the United States Department of Justice and by State Attorneys General.
  • Represented a very senior and global supervising managing director of an international investment bank in an accounting fraud investigation by the United States Department of Justice and the Securities and Exchange Commission.
  • Represented a hedge fund in a corruption investigation by a State Attorney General.
  • Represented the national brand manager of a multinational and publicly traded pharmaceutical and medical device manufacturer in an off-label marketing and health care fraud investigation by the United States Department of Justice.
  • Represented the division president of a North American corporation in a bid rigging investigation by the Antitrust Division of the United States Department of Justice.
  • Represented a very senior and supervising managing director of an international investment bank in a securities fraud investigation by a State Attorney General.
  • Represented an international investment bank in connection with conducting diligence concerning a health care industry issuer.
  • Represented a multinational and publicly traded pharmaceutical and medical device manufacturer in a health care fraud investigation by the United States Department of Justice.
  • Represented a U.S. regional sales director of a multinational and publicly traded pharmaceutical and medical device manufacturer in an off-label marketing and health care fraud investigation by the United States Department of Justice.
  • Represented an international security consultant in an investigation under the Foreign Corrupt Practice Act by the United States Department of Justice.
  • Represented individuals in an investigation of a multinational and publicly traded pharmaceutical maker's manufacturing practices by the United States Department of Justice.
  • Represented a corporation that provided management services to health care providers in False Claims Act litigation brought by the United States Department of Justice and the New York State Attorney General.
  • Represented a corporate director and officer of a publicly traded petroleum company in a stock manipulation investigation by the United States Department of Justice and the Securities and Exchange Commission.

top of page